THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH recalled over manufacturing violations
- Recall date
- October 24, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Unexo Life Sciences Private Limited recalls THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5) and b) 6…
- Recall number
- D-0065-2025
- FDA classification
- Class II
- Brand / firm
- Unexo Life Sciences Private Limited
- Sold / distributed
- Nationwide in the US
Why it was recalled
cGMP Deviations
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5) and b) 6 patches (NDC 71101-001-06, UPC 8 45717 01056 6), Manufactured for: Veridian Healthcare, LLC, Gurnee, IL 60031
Get recall alerts
Free email alert whenever Unexo Life Sciences Private Limited has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Unexo Life Sciences Private Limited